AG
FURX

Artal Group’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Artal Group’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-798,900
Closed -$78.4M – 110
2014
Q1 		$69.5M Sell
798,900
-71,942
-8% -$5.55M 2.52% 7
2013
Q4 		$36.6M Sell
870,842
-100,209
-10% -$4.12M 1.31% 10
2013
Q3 		$42.7M Buy
971,051
+56,609
+6% +$2.34M 1.39% 8
2013
Q2 		$31.2M Buy
+914,442
New +$32.1M 0.98% 12

Artal Group's FURX Position: Q2 2014 in Review

Artal Group sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q2 2014, closing a stake of 798,900 shares — an estimated $78.4M sold.

Artal Group first reported a position in FURX in Q2 2013 and held it in 4 quarters. The position peaked at $69.5M in Q1 2014. 102 funds tracked by Wall St. Rank hold FURX as of Q2 2014.

  • Artal Group reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2014 after selling out during the quarter.
  • Artal Group sold 798,900 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2014, an estimated $78.4M.
  • Artal Group first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 4 quarters.
  • Artal Group's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $69.5M in Q1 2014.
  • 102 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2014.

Based on Artal Group's 13F filing for Q2 2014, filed 14 Aug 2014.